How To Prescribe

Below are the steps you and your patient’s parents take to activate the treatment.

Green border

First, you prescribe the treatment.

Arrow Icon

Send prescription to Phil* pharmacy through either:

Computer Icon

Your EHR:
PhilRx (Columbus, Ohio)

*Phil pharmacy specializes in digital treatment prescriptions, and
manages all prescriptions for EndeavorRx.

Arrow down icon
Divider image


  • Primary ICD-10 code
  • Instructions for play1
  • Number of refills1

1See Instructions for Use

Arrow down icon

Next, parents enroll, pay, and activate.

Parents can enroll online with a phone in a matter of minutes.

Step 1 icon 1

Phil pharmacy texts parents the enrollment link

Arrow right icon
Step 2 icon 2

enroll online

Arrow right icon
Step 3 icon 3

Parents pay and receive activation code

Arrow right icon
Step 4 icon 4

Parents download app and activate treatment

Arrow Icon

Download the app

Try our free demo


© Copyright 2023 Akili Interactive

Arrow Icon
Arrow right icon

Parents should also pair treatment with our free companion app that tracks their child’s in-game progress.

Arrow down icon

Then, guide your patient to make progress.

Follow up

Follow up both during & after treatment to discuss progress and next steps. Empower parents by learning more about our tips for success.



EndeavorRx demonstrates incremental efficacy with two months of treatment, so prescribe with refills. Reach out to Phil for questions.

Green border image

Cost & Coverage

To learn more contact
Phil pharmacy:

If insurance covers EndeavorRx, the out-of-pocket cost will vary based on insurance plan benefits.

Divider image
Divider image

Patient Assistance Program

If EndeavorRx is not covered by an insurance, learn more about our options for making your treatment affordable.

Discover the Program

Have questions? Email Phil at

We’re here to support you.


Indications, Safety and Cautions

EndeavorRx is a digital therapeutic indicated to improve attention function as measured by computer-based testing in children ages 8-12 years old with primarily inattentive or combined-type ADHD, who have a demonstrated attention issue. Patients who engage with EndeavorRx demonstrate improvements in a digitally assessed measure, Test of Variables of Attention (TOVA®), of sustained and selective attention and may not display benefits in typical behavioral symptoms, such as hyperactivity. EndeavorRx should be considered for use as part of a therapeutic program that may include clinician-directed therapy, medication, and/or educational programs, which further address symptoms of the disorder.

No serious adverse events were reported. Of 538 participants in trials supporting EndeavorRx authorization, 50 participants (9.3%) experienced treatment-related adverse events (probable, likely), and three participants experienced treatment-related adverse events with the digital control, in studies where a control was used. Associated adverse events included frustration (6.1%), headache (1.3%), dizziness (0.6%), emotional reaction (0.4%), nausea (0.4%), and aggression (0.2%). All adverse events were generally transient. Only 3 events led to device discontinuation, and no subject reported lasting or irreversible effects after discontinuation.

Rx only: Federal law restricts this device to sale by or on the order of a licensed health care provider. EndeavorRx should only be used by the patient for whom the prescription was written. For medical questions, please contact your child’s healthcare provider. If you are experiencing a medical emergency, please dial 911. EndeavorRx is not intended to be used as a stand-alone therapeutic and is not a substitution for your child’s medication.

If your child experiences frustration, emotional reaction, dizziness, nausea, headache, eye-strain, or joint pain while playing EndeavorRx pause the treatment. If the problem persists contact your child’s healthcare provider. If your child experiences a seizure stop the treatment and contact your child’s healthcare provider.

EndeavorRx may not be appropriate for patients with photo-sensitive epilepsy, color blindness, or physical limitations that restrict use of a mobile device; parents should consult with their child’s healthcare provider.

Please follow all of your mobile device manufacturer’s instructions for the safe operation of your mobile device. For example, this may include appropriate volume settings, proper battery charging, not operating the device if damaged, and proper device disposal. Contact your mobile device manufacturer for any questions or concerns that pertain to your device.